XAIR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XAIR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Beyond Air's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $17.64 Mil. Beyond Air's Total Assets for the quarter that ended in Dec. 2024 was $34.14 Mil. Therefore, Beyond Air's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.52.
The historical rank and industry rank for Beyond Air's Equity-to-Asset or its related term are showing as below:
During the past 10 years, the highest Equity to Asset Ratio of Beyond Air was 0.86. The lowest was -19.91. And the median was 0.50.
The historical data trend for Beyond Air's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air Annual Data | |||||||||||||||||||||
Trend | Jun15 | Jun16 | Dec17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | Mar24 | |||||||||||
Equity-to-Asset | Get a 7-Day Free Trial |
![]() |
![]() |
0.66 | 0.75 | 0.73 | 0.55 | 0.44 |
Beyond Air Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Equity-to-Asset | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.40 | 0.44 | 0.35 | 0.53 | 0.52 |
For the Medical Devices subindustry, Beyond Air's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Beyond Air's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Beyond Air's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as
Equity to Asset (A: Mar. 2024 ) | = | Total Stockholders Equity | / | Total Assets |
= | 25.048 | / | 56.961 | |
= | 0.44 |
Beyond Air's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as
Equity to Asset (Q: Dec. 2024 ) | = | Total Stockholders Equity | / | Total Assets |
= | 17.643 | / | 34.144 | |
= | 0.52 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air (NAS:XAIR) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Thank you for viewing the detailed overview of Beyond Air's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert Carey | director | HORIZON PHARMA, INC., 520 LAKE COOK ROAD, SUITE 520, DEERFIELD IL 60062 |
Michael A. Gaul | officer: Chief Operating Officer | 425 MARTINGALE ROAD, SUITE 1000, SCHAUMBURG IL 60173-2213 |
Steven A. Lisi | director | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Erick Lucera | director | 138 THISTLE ROAD, NORTH ANDOVER MA 08145 |
Amir Avniel | director, officer: President & CEO | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Jeff Lynn Myers | officer: Chief Medical Officer | C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY NY 11530 |
William P Forbes | director | C/O SALIX PHARMACEUTICALS, LTD., 8510 COLONNADE CENTER DRIVE, RALEIGH NC 27615 |
Yoori Lee | director | C/O AIT THERAPEUTICS, INC., 500 MAMARONECK AVENUE, HARRISON NY 10528 |
Ron Bentsur | director | 750 LEXINGTON AVE, 20TH FL, NEW YORK NY 10022 |
Douglas Quinton Larson | officer: Chief Financial Officer | BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY NY 11530 |
Douglas Beck | officer: Chief Financial Officer | C/O IBIO, INC., 9 INNOVATION WAY, SUITE 100, NEWARK DE 19711 |
Ari Raved | director | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Jerome B Zeldis | director | 8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258 |
David Grossman | director | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
Haim Aviv | officer: Chief Financial Officer | 2 ILAN RAMON, SCIENCE PARK, NESS ZIONA L3 7403635 |
From GuruFocus
By Marketwired • 09-27-2024
By GuruFocus News • 02-14-2025
By GuruFocus News • 02-07-2025
By Marketwired • 11-11-2024
By Marketwired • 07-23-2024
By Marketwired • 11-14-2024
By GuruFocus News • 11-08-2024
By Marketwired • 08-06-2024
By Marketwired • 10-07-2024
By Marketwired • 10-29-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.